KLRK1 and neoplasm: MICA and MICB (MHC-class I-associated chain A/B) serve as ligands for NKG2D, which activates the NK cell cytotoxic function by binding to the NKG2D receptors on NK cell surfaces, thus enabling the recognition and destruction of tumor cells that produce these molecules (102).